Home › Funds › Viking Global Investors › LAB
Viking Global Investors position in LAB
STANDARD BIOTOOLS INC · Industrials
Latest position (Q2 2026)58.65M sh
Reported value held$48.25M
Portfolio Weight0.14%
First reportedQ1 2024
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 58.65M | $158.94M | New |
| Q2 2024 | 58.65M | $103.81M | Hold |
| Q3 2024 | 58.65M | $113.20M | Hold |
| Q4 2024 | 58.65M | $102.64M | Hold |
| Q1 2025 | 58.65M | $63.34M | Hold |
| Q2 2025 | 58.65M | $70.38M | Hold |
| Q3 2025 | 58.65M | $76.25M | Hold |
| Q4 2025 | 58.65M | $75.07M | Hold |
| Q1 2026 | 58.65M | $53.92M | Hold |
| Q2 2026 | 58.65M | $48.25M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LAB
- Casdin Capital 88.78M sh · $73.04M · Q2 2026
- Vanguard Group 17.30M sh · $22.14M · Q4 2025
- BlackRock Inc 8.25M sh · $6.79M · Q2 2026
- Royce & Associates 4.53M sh · $3.72M · Q2 2026
- Geode Capital Management 3.90M sh · $3.21M · Q2 2026
- Millennium Management 3.51M sh · $2.89M · Q2 2026
- Morgan Stanley 2.83M sh · $2.33M · Q2 2026
- D. E. Shaw & Co 2.82M sh · $2.32M · Q2 2026
- Citadel Advisors 2.38M sh · $1.96M · Q2 2026
- Arrowstreet Capital 1.99M sh · $1.64M · Q2 2026
- Charles Schwab Investment Management 1.76M sh · $1.45M · Q2 2026